Answers are grounded in this paper and cite their sources.
Fungal infections are increasing in gastroenterology.Cirrhotic patients, liver transplantation recipients, and patients with inflammatory bowel disease (IBD) are vulnerable to these infections.The origin of these fungal infections is frequently the GI tract.The advent of sequencing technology can identify now previously unculturable fungi.Dysbiosis of the mycobiome and microbiome can uncheck normal commensal fungi and turn pathogenic by largely unknown mechanisms Resistance to antifungals is becoming a global problem.New antifungals are in development and they are badly needed.In this mini-review the enteric mycobiota and fungal infections in GI disease are discussed.
No takes yet. Share an insight, caveat, or question.
Michael Ab Naafs (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: